[ad_1]
A recent study from the Gamaleya Center reported that Sputnik V vaccine against coronavirus is most effective against the Delta variant, first detected in India.
From the official Twitter account of the Sputnik V vaccine, they shared the results obtained by the Russian public medical research center on Tuesday morning.
“#SputnikV is more effective against the Delta variant of the coronavirus, first detected in India Than any other vaccine that has published results on this strain so far: the Centro Gamaleya study submitted for publication in an international peer-reviewed journal, ”they announced.
The beta is advancing, and it’s worse than the delta: it already “escapes” the effect of two vaccines and causes the third wave in a key country
It should be mentioned that a report from the PAIS project, the consortium of researchers established by the Ministry of Science, Technology and Innovation to monitor variants of SARS-CoV-2 and study its evolution in Argentina, confirmed a few days ago the Delta variant has been detected in at least “59 countries, including Brazil and Argentina in Latin America”.
Likewise, in radio statements, the director of migration, Florencia Carignano, ratified last week that two cases of coronavirus of the aforementioned variant have been detected in Argentina, one of the “worrying” according to the World Health Organization (WHO).
For who, “It has become evident that more public health risks are currently associated with the delta, while lower transmission rates were observed with the other lineages. ”
Delta, the variant of the coronavirus that worries the WHO: more contagious and “little” protection with a single dose
WHAT HAPPENS TO THE DELTA VARIANT AND THE PFIZER AND ASTRAZENECA Vaccines
Following the announcement by British Prime Minister Boris Johnson, who confirmed that UK deconfinement will be postponed – started in December– for a month due to the growth of cases of the Delta variant – around 7,000 per day– concerns about the effectiveness of the most widely used vaccines against this new strain, estimated at 60% more contagious than the Alpha variant, appeared in the UK last year.
Coronavirus: Delta variant pushes infections and complicates reopening of activities
However, a study by British health authorities indicates that having received the two doses of the Pfizer / BioNTech and AstraZeneca / Oxford vaccines protects effectively against hospitalization.
From the document, it is extracted that those who received the two doses of Pfizer, they will be protected in a 96% versus hospitalizations. For their part, people vaccinated with the full schedule of AstraZeneca are protected in a 92% against hospitalization due to the India variant.
“It is absolutely vital to receive both doses as soon as they are offered for maximum protection against all existing and emerging variants.“said Mary Ramsay, responsible for vaccination at PHE, against these results.
.
[ad_2]
Source link